FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Fresenius Kabi USA LLC (FK USA) Irinotecan Hydrochloride Injection Recall

IRINOTECAN HYDROCHLORIDE INJECTION, 40 mg/2 mL (20 mg/mL), 2 mL Single Dose Vial, Rx on…

Fresenius Kabi USA LLC (FK USA) · Schaumburg, IL

Risk level
Class II
Reported by FDA
Aug 28, 2013
Recall ID
D-915-2013
Check your lot numberHow we source this data

Summary

Fresenius Kabi USA LLC (FK USA) recalled Irinotecan Hydrochloride Injection starting Jan 22, 2013. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-915-2013 on Aug 28, 2013. Reason: Crystallization: Active pharmaceutical ingredient is precipitating in product solution. Status: Terminated.

Why it was recalled

Crystallization: Active pharmaceutical ingredient is precipitating in product solution.

Product description

IRINOTECAN HYDROCHLORIDE INJECTION, 40 mg/2 mL (20 mg/mL), 2 mL Single Dose Vial, Rx only, Manufactured for: APP Pharmaceuticals, LLC, Schaumburg, IL 60173, NDC 63323-193-02, UPC 3 63323 19302 7.

Lot numbers, UPCs & expiration codes

Lot #: 872CZ00101, Exp 12/13

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-915-2013
Classification
Class II
Status
Terminated
Recall initiated
Jan 22, 2013
FDA report date
Aug 28, 2013
Quantity
23,672 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Fresenius Kabi USA LLC (FK USA)

Original FDA data

Every field from FDA enforcement report D-915-2013, exactly as published.

Show all FDA fields
City
Schaumburg
State
IL
Status
Terminated
Country
United States
Event ID
64102
Address
1501 E Woodfield Rd
Address (line 2)
Suite 300 East
Code information
Lot #: 872CZ00101, Exp 12/13
Postal code
60173-6052
Report date
Aug 28, 2013
Product type
Drugs
Recall number
D-915-2013
Classification
Class II
Recalling firm
Fresenius Kabi USA LLC (FK USA)
Product quantity
23,672 vials
Termination date
May 12, 2015
Reason for recall
Crystallization: Active pharmaceutical ingredient is precipitating in product solution.
Voluntary / mandated
Voluntary: Firm initiated
Product description
IRINOTECAN HYDROCHLORIDE INJECTION, 40 mg/2 mL (20 mg/mL), 2 mL Single Dose Vial, Rx only, Manufactured for: APP Pharmaceuticals, LLC, Schaumburg, IL 60173, NDC 63323-193-02, UPC 3 63323 19302 7.
Distribution pattern
Nationwide
Recall initiation date
Jan 22, 2013
Initial firm notification
Letter
Center classification date
Aug 21, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-915-2013, published Aug 28, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls